Literature DB >> 30370095

Separate or intrapulmonary metastasis?

Yu-Chao Yu1,2, Chien-Sheng Huang1,3, Biing-Shiun Huang1.   

Abstract

Year:  2018        PMID： 30370095      PMCID： PMC6186628          DOI： 10.21037/jtd.2018.08.74

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  9 in total

1.  Surgical results of synchronous multiple primary lung cancers: similar to the stage-matched solitary primary lung cancers?

Authors:  Yu-Chao Yu; Po-Kuei Hsu; Yi-Chen Yeh; Chien-Sheng Huang; Chih-Cheng Hsieh; Teh-Ying Chou; Han-Shui Hsu; Yu-Chung Wu; Biing-Shiun Huang; Wen-Hu Hsu
Journal:  Ann Thorac Surg       Date:  2013-09-07       Impact factor: 4.330

2.  A dominant adenocarcinoma with multifocal ground glass lesions does not behave as advanced disease.

Authors:  Bo Gu; Bryan M Burt; Robert E Merritt; Stephanie Stephanie; Viswam Nair; Chuong D Hoang; Joseph B Shrager
Journal:  Ann Thorac Surg       Date:  2013-06-24       Impact factor: 4.330

3.  Survival of a surgical series of lung cancer patients with synchronous multiple ground-glass opacities, and the management of their residual lesions.

Authors:  Yoshihisa Shimada; Hisashi Saji; Keishi Otani; Sachio Maehara; Junichi Maeda; Koichi Yoshida; Yasufumi Kato; Masaru Hagiwara; Masatoshi Kakihana; Naohiro Kajiwara; Tatsuo Ohira; Soichi Akata; Norihiko Ikeda
Journal:  Lung Cancer       Date:  2015-03-01       Impact factor: 5.705

4.  Multiple primary lung cancers.

Authors:  N Martini; M R Melamed
Journal:  J Thorac Cardiovasc Surg       Date:  1975-10       Impact factor: 5.209

5.  The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

Authors:  Stephen B Edge; Carolyn C Compton
Journal:  Ann Surg Oncol       Date:  2010-06       Impact factor: 5.344

6.  Favorable prognosis and high discrepancy of genetic features in surgical patients with multiple primary lung cancers.

Authors:  Kezhong Chen; Wei Chen; Jianqiao Cai; Fan Yang; Feng Lou; Xun Wang; Jingbo Zhang; Mingyu Zhao; Jay Zhang; Jun Wang
Journal:  J Thorac Cardiovasc Surg       Date:  2017-10-05       Impact factor: 5.209

7.  Treatment outcomes for patients with synchronous multiple primary non-small cell lung cancer.

Authors:  Eun Jung Jung; Jong Hoo Lee; Kyeongman Jeon; Won-Jung Koh; Gee Young Suh; Man Pyo Chung; Hojoong Kim; O Jung Kwon; Young Mog Shim; Sang-Won Um
Journal:  Lung Cancer       Date:  2010-12-09       Impact factor: 5.705

8.  Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Benjamin D Kozower; James M Larner; Frank C Detterbeck; David R Jones
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

9.  Stage I synchronous multiple primary non-small cell lung cancer: CT findings and the effect of TNM staging with the 7th and 8th editions on prognosis.

Authors:  Jingxu Li; Xinguan Yang; Tingting Xia; Yubao Guan; Nanshan Zhong
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895
  9 in total
  3 in total

1.  Synchronous multiple lung cancers presenting as multifocal pure ground glass nodules: are whole-body positron emission tomography/computed tomography and brain enhanced magnetic resonance imaging necessary?

Authors:  Meng Li; Yuan Wan; Li Zhang; Li-Na Zhou; Zhuo Shi; Rui Zhang; Yan-Lei Hou; Ning Wu
Journal:  Transl Lung Cancer Res       Date:  2019-10

2.  Prognostic histologic subtyping of dominant tumor in resected synchronous multiple adenocarcinomas of lung.

Authors:  Ping-Chung Tsai; Chia Liu; Yi-Chen Yeh; Chun-Ku Chen; Po-Kuei Hsu; Hui-Shan Chen; Chien-Sheng Huang; Chih-Cheng Hsieh; Han-Shui Hsu; Biing-Shiun Huang
Journal:  Sci Rep       Date:  2021-05-05       Impact factor: 4.379

3.  Application Value of PET/CT and MRI in the Diagnosis and Treatment of Patients With Synchronous Multiple Pulmonary Ground-Glass Nodules.

Authors:  Shaonan Xie; Shaoteng Li; Huiyan Deng; Yaqing Han; Guangjie Liu; Qingyi Liu
Journal:  Front Oncol       Date:  2022-02-23       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.